New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 20, 2013
12:02 EDTRGRXRegeneRx receives notice of allowance from Canadian patent office
RegeneRx Biopharmaceuticals announced that it has received a Notice of Allowance of a Canadian patent application for using Thymosin beta 4 and various fragments and other related peptides for inhibiting or reversing skin aging. The patent will expire in 2021.
News For RGRX From The Last 14 Days
Check below for free stories on RGRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for RGRX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use